No more post-implant errors
Clerio is working on a technology to write corrections into some existing intraocular lenses (IOLs). The technology will offer the ability to correct post-implant refractive errors. It can also convert monofocal IOLs into multifocal IOLS. These adjustments can be made over the life of the patient, achieving optimal outcomes in vision correction.
Improving outcomes
More than half of the cataract surgeries performed annually result in a residual refractive error, or the difference between the intended correction and the actual correction. Sometimes this result occurs because an IOL shifts after surgery. Even such a small shift can significantly impact vision.
Unlike other technologies, LIRIC has a unique capability to write precision corrections into existing IOLs. LIRIC also has the ability to modify prescriptions multiple times without an invasive procedure.
ABOUT CLERIO VISION
Clerio Vision was founded based on groundbreaking research from the University of Rochester using femtosecond lasers for noninvasive vision correction in contact lenses, the human cornea and intraocular lenses (IOLs). We are dedicated to providing a wide array of solutions to the millions of patients requiring vision correction.
Headquarters
& Operations
1892 S. Winton Rd.
Rochester, NY 14618
Contact Lens
Manufacturing & Sales
7575 Commerce Court
Sarasota, FL 34243
Contact Lens
Research Center
205 Summit Point Dr.
Henrietta, NY 14467
Refractive Surgery
Research Center
1435 Koll Circle Suite 105
San Jose, CA 95112